Ketchum Steven B

EVP, Chief Scientific OfficerAMARIN CORP PLC\UK (AMRN) · full profile →Form 4 · filed Feb 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
4 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2026Option exercise(M)2K42K
Jan 31, 2026Option exercise(M)2K41K
Jan 31, 2026Tax withholding(F)1K$15.42$19K40K
Jan 31, 2026Tax withholding(F)1K$15.42$16K41K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 1, 2026Grant(A)36K$036K
Feb 1, 2026Grant(A)8K$08K
Jan 31, 2026Option exercise(M)2K$00
Jan 31, 2026Option exercise(M)2K$02K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-036169) within minutes of acceptance. Every field above traces to the original document. Verify it directly: